MMP9 and breast cancer: Studies have also shown that GATA binding protein 4 (GATA4) recruits histone deacetylase, resulting in reduced acetylation of the transcription factor p65, thereby inhibiting p65 binding to the MMP9 promoter, inhibiting the transcriptional activity of MMP9, and preventing breast cancer metastasis [20].